Cancer Treatment

SCIENTIFIC PUBLICATIONS

The truth is that a simple review of studies on cancer and mistletoe appeared in Publiman sample of the great interest and confirms what we have written so far. Citing only some of the studies of recent years has shown we find that response to different types of cancer.

This applies to a 2004 study on breast cancer led by Lin HS is published as Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial. This is a prospective multicenter, randomized, open and conducted in three cancer centers in the People’s Republic of China: Beijing, Tianjin and Shenyang. The study was conducted along the guidelines known as Good Clinical Practice (GCP) to obtain data on the efficacy and side effects of mistletoe extract. However, “this study shows it is said in the conclusions-that the adjuvant mistletoe extract can beneficially reduce the side effects of chemotherapy in cancer patients and improve their quality of life.”

Two years later, in October 2006 – Ziegler would release another study on breast cancer entitled Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador). And in that case would begin recognizing the role of mistletoe: mistletoe preparations derived as Iscador-can read it-are commonly used in the CAM / anthroposophic for many types of cancer, particularly solid cancers. Well, the study would conclude that the long-term effect on the progression of Iscador in most cases is significant, as well as on overall survival.

“Iscador-stated in the conclusions, showing a clinically relevant effect on breast tumor progression, as measured by overall survival, as well as time to recurrence, lymph node or distant metastasis. In the short term, psychosomatic self-regulation increases significantly lower complementary Iscador therapy than with conventional therapy alone.
The same researchers publish in June 2007 a new investigation, this time on cervical cancer, entitled Prospective controlled cohort studies on long-term therapy of cervical cancer patients with a mistletoe preparation (Iscador). And in his return to draw conclusions that Iscador appears capable of extending overall survival, this time among patients with cervical cancer. In addition to improving quality of life. The same conclusion would later study on the effects of mistletoe in cancer of the ovary.

And they are only a few samples. Even in cancers considered very difficult to deal with encouraging results have been obtained. In 1996, for example, was published Treatment of advanced pancreatic cancer with mistletoe: results of a pilot trial of Buchler MW et al. This was a phase I / II in which we evaluated the effect of an extract of mistletoe (Eurixor) in 16 patients (7 women and 9 men) with histologically verified ductal pancreatic carcinoma. And although the results suggest that mistletoe does not have a significant influence on tumor growth in advanced pancreatic cancers do indicate that “can stabilize the quality of life and therefore help patients maintain their quality of life in the few months remaining in their life. “

We can also find good results against hepatitis C. In a 2005 study led by Dutchman Hattum J. on 21 patients with hepatitis C, the results suggested an effect comparable to treatment glicirrínico: an improvement in liver inflammation and, therefore, possible long-term reduction of complications such as cirrhosis and liver cancer. “Preparations of mistletoe-add-have the advantage of easy administration and low cost.”

THE DOCTOR’S ANGEL SPANISH EXPERIENCE Borruel
We must say, in conclusion, that during the preparation of this report we are in Internet -www.medicina-naturista.net/Congreso_Malaga_2004/Congreso_2004.htm- the paper that a Spanish doctor, Angel Borruel Omenat-member of the Spanish Association of Physicians Naturists, was introduced in Congress Naturist Medicine and Oncology in November 2004 in the Faculty of Medicine of Granada. Fortunately it was easy to locate and more talk. And that brings seventeen years Borruel using in your query Huesca mistletoe in cancer patients. As we would have had knowledge of its effectiveness through Anthroposophical Medicine-of-specialist who is also after doing a course at a clinic-the anthroposophical Lukas Arlesheim Clinik (Switzerland) – specializing in cancer where the mistletoe is fundamental treatment.
Mistletoe-start-telling “is the most widely used oncology product in Germany, including chemotherapeutic drugs of any kind, because it is perfectly compatible with any conventional treatment.
“And after 17 years of use, what can make us overall assessment of its usefulness in treating cancer?
“In cancer, the results are always the mistletoe because it strengthens the immune system and inhibits the oncogenes that stimulate angiogenesis and prevents apoptosis. At the least, improves quality of life of patients: appetite, energy and mood. In my practice of natural medicine see patients of all kinds and I would not be considered statistically valid, but in Germany, where many patients treated with mistletoe, there are studies that clearly is the increase in life expectancy. This is the case Grossarth-Maticek study done in 2002, for example, which examined 10,226 cases of patients with carcinoma of the colon, rectum, stomach, breast and lung. Of these 1668 were treated with Iscador (VAF in Spain) obtaining a longer life expectancy taxed at 40%. And when there was also a level of self-regulation in the patient is cared for, was on a diet, exercised, etc. .- the difference in expected survival reached 56%. As if today is a drug that increases life expectancy by 56% would be opening news in all news programs.
- Also affects the tumor growth mistletoe?
“It seems that in some cases and although the effect is not so much on the tumor cell as the immune system that strengthens it. The presentation of the conference held in Granada presented the case of a 17 year old girl with an astrocytoma of 3 cm with a large cerebral edema. In November 2000 he was given a life expectancy of two months. He had found two years earlier, underwent surgery and chemotherapy was administered but reappeared two years in an area where the surgery was impossible for him to be turned back to the chemo to no avail. The patient, neurologically, increasingly got worse. In November oncologists decided to suspend the chemo did not get to see any results nor gave him hope. Then started treatment with mistletoe .. but not with the VAF is marketed in Spain as in intracranial tumors can raise the blood pressure of spinal fluid. We start with a type of mistletoe called Isorel and no longer sold in Spain so we had to ask for Germany. He applied intravenously in very high doses-we put up to 20 blisters on a drip at a time-and we were changing the dose. The patient began to feel better neurologically. In spring resonance image was like in the fall but was much better neurologically. To the extent that at the end of course could participate in the concert at the conservatory. He had to give up music for their neurological problems. In the fall the tumor had already been halved and edema to a fourth or a fifth. Today the tumor is still there. Just talked to his mother last week and the oncologist had told him that the tumor was slightly better but still present. In short, we reduce the tumor and edema getting the patient to lead a completely normal life. Today is still clicking but now under the skin. Of course, other patients with astrocytoma have not been so lucky.
“Among other reasons, we assume, because when patients come to you with the disease are already at an advanced stage …
“It’s true. The vast majority get very damaged. Almost never do the first diagnosis. I already come with whatever reports were made.
“And in the cases that have come sooner, what was the outcome?
“Right now I have a patient who began treatment in early December. I was the first he saw her as a doctor. I recommended myself to go to Social Security because it had a huge tumor in her right breast but while waiting to be made all the tests I tried with mistletoe, ozone therapy at high doses, Papimi-joined this device to my office after learning to fund their chances in the last congress organized DSALUD Discovery, changed his diet, I take flax oil in large quantity and recommended antifungal therapy. The right breast tumor was reduced by 10% in little over a month and a half. Indeed, from early January to late February infiltration of the left breast tumor has completely disappeared. Just today (meaning the day we had the conversation that the reader is reading) has seen an oncologist and has said he wants to continue with the treatment of mistletoe. With the tests complete the proposed chemotherapy treatment but for now she prefers to stick with the mistletoe. We do not know where to get. One must be cautious in this. I normally try to terminally ill cancer patients with mistletoe and precancerous. Although all cases of cervical cancer that I have tried, some even in grade three, they have to negative. Always with subcutaneous injection because the oral route is much less effective. My advice also is to follow the lifelong treatment but with different dose and timing.
“What you normally do then is to complement conventional treatments …
“Yes. For example, it is common for patients who have come chemo scheduled, a drip of chemo every three weeks, but can not complete the cycle as a result of side effects, anemia, leukopenia … and thus have four weeks to distance. Then begin with the mistletoe and almost always recover the hematological level. Not until a normal level but to a level enough to get chemo every three weeks. The mistletoe is perfectly complementary with the chemo because adequate doses have no side effects.
-In your experience, is there some kind of tumor more susceptible to improvement treated with mistletoe?
“Except for lung cancer Small cell leukemia cases and all others are susceptible of improvement with the mistletoe. Both a hepatocellular adenoma and prostate cancer, an ovarian tumor as a breast or colon. In the worst response is achieved at least there is improvement in quality of life. But I never do alone. Additionally use mistletoe other therapeutic tools I mentioned before so you never know for sure what degree of improvement corresponds to each part of the treatment but I can tell you that mistletoe I put in a tumor ever. All patients with tumors that have tried for 17 years I have treated with mistletoe.
- Is also effective in the case of metastases?
“In my paper I presented another case, a woman with metastatic hypernephroma hip, lung metastases and another possible impairment. He had said only: “Go home and use pain medications as needed. When we started treatment with VAF Mali had enough pain in the hip. However, the third injection, is usually not as fast, “he began feeling better and hip pain disappeared soon after. Six months after the lung metastases had disappeared and the liver can form a tumor that was said was treatable intractable so just undergoing surgery and conventional treatment. The paradox here is that the patient ended up leaving with mistletoe treatment recommended by his oncologist.
“Being the most widely used oncology product in Germany, what attributes the ignorance that oncologists in Spain seem to have of him?
“I think that oncologists know it all but neither recommend it nor use it. Here we encountered the power of multinationals. I put my hand in the fire for the efficacy of mistletoe to improve the quality of life and survival. Sometimes even by healing the sick. But I fear that oncologists will receive information from the drug multinationals so skewed that they do not conceive it possible to achieve these results with the mistletoe. I’m not saying they have ill will. I believe as a physician that the vast majority of my colleagues want to cure their patients but clearly they are driven by information, at least, wrong. The first patient I treated was 17 years ago a young man of 30 years with adenocarcinoma of the pancreas with metastases in liver and lung. I talked to his oncologist because the family asked me and he said they were going to give palliative chemotherapy without any hope, just to see if they could prolong her life. We begin with the mistletoe and first disappeared lung and liver metastases. It was only with the primary tumor and that was removed surgically. That man is still alive. I do not know how much of his survival was the mistletoe. And I know because I was also getting chemo but given the expectations that had given it seems to me that the role of mistletoe was significant.
“Neither seem to be widely used mistletoe among naturopathic doctors …
“No, do not use it much, unfortunately. Whenever I get together with a colleague at conferences or courses will talk about the results of mistletoe in cancer because I am convinced how well it goes. At the least, improves quality of life for what the patient and patients are grateful. I think Weleda, Swiss drugmaker manufacturer does not make a good media campaign and training among doctors prone to natural medicine.
“One last question: treatment with mistletoe should always be in control of a professiona.